Pharmaceutical company spending on research and development and promotion in Canada, 2013-2016: a cohort analysis
Background Competing claims are made about the amount of money that pharmaceutical companies spend on research and development (R&D) versus promotion. This study investigates this question in the Canadian context. Methods Two methods for determining industry-wide figures for spending on promotio...
Saved in:
Main Author: | Joel Lexchin (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2018-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Donations Made and Received: A Study of Disclosure Practices of Pharmaceutical Companies and Patient Groups in Canada
by: Joel Lexchin
Published: (2022) -
Development Time and Patent Extension for Prescription Drugs in Canada: A Cohort Study
by: Joel Lexchin
Published: (2021) -
Models for financing the regulation of pharmaceutical promotion
by: Lexchin Joel
Published: (2012) -
It's Time to Finally Kill the Zombies; Comment on "Universal Pharmacare in Canada"
by: Joel Lexchin
Published: (2020) -
Canada's Patented Medicine Notice of Compliance regulations: balancing the scales or tipping them?
by: Lexchin Joel
Published: (2011)